Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1

Clinical trial NCT00000738 · COMPLETED

Trial details

NCT number

NCT00000738

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Enrollment

36

View on ClinicalTrials.gov